Cargando…

Surgical options for submucosal tumors near the esophagogastric junction: does size or location matter?

BACKGROUND: Submucosal tumors (SMTs) of different etiologies exist from esophagus to rectum. Esophagogastric junction (EGJ) is one of the known difficult locations for tumor resection. Although minimally invasive surgery (MIS) is a well-established approach for gastrointestinal surgery, there is no...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Yi-Chun, Yeh, Chun-Nan, Chen, Ming-Yang, Wang, Shang-Yu, Liu, Keng-Hao, Tsai, Chun-Yi, Yeh, Ta-Sen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7430816/ https://www.ncbi.nlm.nih.gov/pubmed/32762661 http://dx.doi.org/10.1186/s12893-020-00840-6

Ejemplares similares

Laparoscopic Local Resection through Subserosal Dissection with Endoscopic Air-Insufflation for Submucosal Tumors Located Near the Esophagogastric Junction
por: Kim, In-Kyeong, et al.
Publicado: (2020)

Laparoscopic and Endoscopic Cooperative Surgery for Gastric Submucosal Tumor Near Esophagogastric Junction With Sliding Hiatal Hernia
por: Kashima, Hajime, et al.
Publicado: (2023)

Clinical Efficacy of Endoscopic Submucosal Dissection for Adenocarcinomas of the Esophagogastric Junction
por: Nagami, Yasuaki, et al.
Publicado: (2014)

Everolimus Related Fulminant Hepatitis in Pancreatic Neuroendocrine Tumor With Liver Metastases: A Case Report and Literature Review
por: Chang, Shih-Chun, et al.
Publicado: (2021)

Priority of lymph node dissection for advanced esophagogastric junction adenocarcinoma with the tumor center located below the esophagogastric junction
por: Cai, Ming-Zhi, et al.
Publicado: (2019)

Endoscopic submucosal dissection for early esophagogastric junction adenocarcinomas: a systematic review
por: Doumbe-Mandengue, Paul, et al.
Publicado: (2022)

Blood-based Markers in the Prognostic Prediction of Esophagogastric Junction Cancer
por: Liu, Can-Tong, et al.
Publicado: (2020)

Non‐small cell lung cancer with gastric metastasis and repeated gastrointestinal bleeding: A rare case report and literature review
por: Shih‐Chun, Chang, et al.
Publicado: (2021)

Endoscopic and Laparoscopic Full-Thickness Resection of Endophytic Gastric Submucosal Tumors Very Close to the Esophagogastric Junction
por: Kwon, Oh Kyoung, et al.
Publicado: (2015)

Comparison of different endoscopic resection techniques for submucosal tumors originating from muscularis propria at the esophagogastric junction
por: Xu, Hong-wei, et al.
Publicado: (2019)

Predictors of difficult endoscopic resection of submucosal tumors originating from the muscularis propria layer at the esophagogastric junction
por: Wang, Yu-Ping, et al.
Publicado: (2022)

N3 Subclassification Incorporated into the Final Pathologic Staging of Gastric Cancer: A Modified System Based on Current AJCC Staging
por: Yeh, Chun-Nan, et al.
Publicado: (2015)

A nomogram for predicting the probability of recurrence in patients with carcinomas located in the ampulla of Vater
por: Liu, Keng-Hao, et al.
Publicado: (2017)

“A hybrid approach for GISTs near the esophagogastric junction, a case report”
por: Aguayo, William G., et al.
Publicado: (2021)

Prediction of Gastric Gastrointestinal Stromal Tumors before Operation: A Retrospective Analysis of Gastric Subepithelial Tumors
por: Lin, Yu-Ning, et al.
Publicado: (2022)

Regorafenib treatment outcome for Taiwanese patients with metastatic gastrointestinal stromal tumors after failure of imatinib and sunitinib: A prospective, non-randomized, single-center study
por: Hu, Chia-Hsiang, et al.
Publicado: (2020)

Selective reoperation after primary resection as a feasible and safe treatment strategy for recurrent pancreatic cancer
por: Chang, Shih-Chun, et al.
Publicado: (2016)

Prognostic Value of the Metastatic Lymph Node Ratio in Patients With Resectable Carcinoma of Ampulla of Vater
por: Hsu, Chih-Ho, et al.
Publicado: (2015)

Prospective Evaluation of Neoadjuvant Imatinib Use in Locally Advanced Gastrointestinal Stromal Tumors: Emphasis on the Optimal Duration of Neoadjuvant Imatinib Use, Safety, and Oncological Outcome
por: Wang, Shang-Yu, et al.
Publicado: (2019)

Hepatectomy or/with Metastatectomy for Recurrent Intrahepatic Cholangiocarcinoma: Of Promise for Selected Patients
por: Tsai, Chun-Yi, et al.
Publicado: (2022)

Integrative proteomic characterization of adenocarcinoma of esophagogastric junction
por: Li, Shengli, et al.
Publicado: (2023)

Accuracy of Preoperative Endoscopy in Determining Tumor Location Required for Surgical Planning for Esophagogastric Junction Cancer
por: Okumura, Koichi, et al.
Publicado: (2021)

Mapping of lymph node dissection determined by the epicenter location and tumor extension for esophagogastric junction carcinoma
por: Liang, Rong, et al.
Publicado: (2022)

Characterization of intrahepatic cholangiocarcinoma after curative resection: outcome, prognostic factor, and recurrence
por: Chan, Kun-Ming, et al.
Publicado: (2018)

Cytoreductive Surgery may be beneficial for highly selected patients with Metastatic Gastrointestinal Stromal Tumors receiving Regorafenib facing Local Progression: A Case Controlled Study
por: Yeh, Chun-Nan, et al.
Publicado: (2021)

Metabolism of Proteins and Amino Acids in Critical Illness: From Physiological Alterations to Relevant Clinical Practice
por: Hsu, Chih-Chieh, et al.
Publicado: (2021)

Recent advances in multidisciplinary therapy for adenocarcinoma of the esophagus and esophagogastric junction
por: Zheng, Yi-Han, et al.
Publicado: (2022)

Novel abdominal approach for dissection of advanced type II/III adenocarcinoma of the esophagogastric junction: a new surgical option
por: Hu, Can, et al.
Publicado: (2018)

Particulate Matter Exposure in a Police Station Located near a Highway
por: Chen, Yu-Cheng, et al.
Publicado: (2015)

The impact of preoperative etiology on emergent pancreaticoduodenectomy for non-traumatic patients
por: Tsai, Chun-Yi, et al.
Publicado: (2017)

Treatment Options for T1 Stage Adenocarcinoma of Esophagogastric Junction: A Real-World Retrospective Cohort Study
por: Zhou, Xiaoying, et al.
Publicado: (2021)

An extra 1-cm margin during endoscopic submucosal dissection can control subsquamous tumor extension of esophagogastric junction adenocarcinoma
por: Manabe, Taku, et al.
Publicado: (2022)

Esophageal Stent for Cervical Esophagus and Esophagogastric Junction
por: Shim, Chan Sup
Publicado: (2012)

Current surgical treatment of esophagogastric junction adenocarcinoma
por: Zhang, Shun, et al.
Publicado: (2019)

Esophagogastric Junction Outflow Obstruction Caused by Gabapentin
por: Barret, Maximilien, et al.
Publicado: (2019)

Feasibility and Timing of Cytoreduction Surgery in Advanced (Metastatic or Recurrent) Gastrointestinal Stromal Tumors During the Era of Imatinib
por: Chang, Shih-Chun, et al.
Publicado: (2016)

Combined detection of serum autoantibodies as diagnostic biomarkers in esophagogastric junction adenocarcinoma
por: Xu, Yi-Wei, et al.
Publicado: (2018)

Esophageal Bolus Domain Pressure and Peristalsis Associated With Experimental Induction of Esophagogastric Junction Outflow Obstruction
por: Lei, Wei-Yi, et al.
Publicado: (2022)

Comparing long-term outcomes between endoscopic submucosal dissection (ESD) and endoscopic mucosal resection (EMR) for type II esophagogastric junction neoplasm
por: Liu, Yong, et al.
Publicado: (2021)

Serum CYR61 as a potential biomarker for the diagnosis of esophagogastric junction tumor
por: Chu, Ling-Yu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_cbi6vg4bra010nbocug6bs3gmu